increase by ~200 mcg every 2 weeks as tolerated
Commonly reported side effects from peptide use include mild injection site reactions (redness, discomfort), temporary fatigue, headache, and occasional nausea
Test before supplementing megadoses
BPC-157 is a synthetic pentadecapeptide stabilised against acid hydrolysis, acting through multiple receptor systems including VEGFR2, FAK (focal adhesion kinase), EGR1 (early growth response protein 1), and eNOS to produce angiogenesis, tissue repair, anti-inflammatory, and neuroprotective effects
Staggered Injections Peptides that target different receptors can be injected at the same time
Beyond receptor biology, AOD9604 serves as an important analytical reference material in ligand-binding studies, analytical chemistry, peptide stability investigations, pharmacodynamic research, molecular characterization, biomarker evaluation, and assay optimization